Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 260 participants.
Also called NCT02627521
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 260 participants
- Sponsor
- Registry
-
NCT02627521
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Unknown status
Technical summary
Registry record NCT02627521. Randomized; triple masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2017-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor
- Acronym
- CABG-TIME
- Condition
- Coronary Artery Disease
- Intervention (Procedure)
- PRU guided CABG (coronary artery bypass grafting)
- Intervention (Procedure)
- CABG per standard of care
- Intervention (Device)
- VerifyNow assay
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Unity Health Toronto
Record details
- Record id
cardio:ct-nct02627521- Content hash
7fe634aaee9f1c5193021861753e439da4aa475010e54d87a979d37701045e5e